Properties of G-martingales with finite variation and the application to G-Sobolev spaces

As is known, if $B={\left(B_t\right)}_{t\in [0,T]}$ is a $G$-Brownian motion, a process of form ${\int }_0^t{\eta }_{s}d{〈B〉}_s?{\int }_0^{t}2G\left({\eta }_s\right)ds$, $\eta \in M_G^1(0,T)$, is a non-increasing $G$-martingale. In this paper, we shall show that a non-increasing $G$-martingale cannot be form of ${\int }_0^t{\eta }_{s}ds$ or ${\int }_0^t{\gamma }_{s}d{〈B〉}_s$, $\eta ,\gamma \in M_G^1(0,T)$, which implies that the decomposition for generalized $G$-Itô processes is unique: For arbitrary $\zeta \in H_G^1(0,T)$, $\eta \in M_G^1(0,T)$ and non-increasing $G$-martingales $K,L$, if ${\int }_0^t{\zeta }_{s}d{B}_s+{\int }_0^t{\eta }_{s}ds+K_t=L_t,t\in [0,T],$then we have $\eta \equiv 0$, $\zeta \equiv 0$ and$K_t=L_t$. As an application, we give a characterization to the $G$-Sobolev spaces introduced in Peng and Song (2015).     

Simultaneous quantitation of 23 bioactive compounds in Tanreqing capsule by high‐performance liquid chromatography electrospray ionization tandem mass spectrometry

Tanreqing capsule (TRQC) is a formulation frequently used in traditional Chinese medicine to treat pyrexia, cough, expectoration and pharyngalgia. Since the pharmacological action of traditional Chinese medicines is closely related to their complex and diverse constituents, understanding the exact composition of TRQC is important to elucidate its clinical effectiveness and mechanism of action as well as to establish quality control methods and resolve safety issues. Herein, we employed high‐performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry for the simultaneous quantitation of 23 bioactive compounds in five batches of TRQC; the analytes could be categorized into five types: organic acids (seven compounds), flavonoids (10 compounds), iridoids (two compounds), phenylethanoid glycosides (two compounds) and bile acids (two compounds). The calibration curves for all analytes showed good linearity (r > 0.9953), and the inter‐ and intra‐day precisions did not exceed 4.94 and 4.97%, respectively. The recoveries varied from 90.47% to 109.80%; the corresponding relative standard deviations (RSDs) did not exceed 4.94%; and the repeatability (RSD < 4.72%) and stability (RSD < 4.88%) were also within acceptable limits. Thus, this study can be viewed as a fundamental reference for setting comprehensive TRQC quality standards.     

立体化学在有机化学中的重要地位——中国化学奥林匹克竞赛理论试题分析

分析2015-2017年中国化学奥林匹克竞赛（初赛、决赛）理论部分试题，发现有机化学试题中立体化学相关内容备受命题者的青睐，凸显了立体化学在有机化学中的重要地位。     

Comparative in vivo constituents and pharmacokinetic study in rats after oral administration of ultrafine granular powder and traditional decoction slices of Chinese Salvia

Salvia miltiorrhiza, one of the most well‐known herbal medicines, is commonly used for the treatment of coronary heart diseases in China. Besides traditional decoction slices (TDS), another relatively new product of S. miltiorrhiza, ultrafine granular powder (UGP; D90 < 45 μm), is also increasingly being used. In this paper, a UHPLC‐LTQ‐Orbitrap MS technique was developed for a metabolite profile study after oral administration of UGP and TDS of S. miltiorrhiza. The results showed that the number of in vivo absorbed compounds from UGP was much greater than that from TDS, and different types of products from S. miltiorrhiza will have different metabolic processes in vivo. Furthermore, a UHPLC‐Q‐Trap MS/MS method for simultaneously determining four tanshinones (tanshinone IIA, dihydrotanshinone I, tanshinone I and cryptotanshinone) was established and applied to assess the pharmacokinetics of the two types of products. All of the analytes displayed significant higher area under the concentration–time curve and peak concentration after oral administration of UGP than after TDS, indicating that ultrafine powder product could improve the bioavailability and absorption of cryptotanshinon,tanshinone II A,dihydrotanshinonE I and tanshinone I in vivo. The present study provides scientific information for further exploration of the pharmacology of these two types of S. miltiorrhiza and offers a reference for clinical administration of S. miltiorrhiza.     

Rapid quantitative analysis of etoricoxib in human plasma by UPLC‐MS/MS and application to a pharmacokinetic study in Chinese healthy volunteers

A selective and sensitive liquid chromatography–tandem mass spectrometry method was developed for simultaneous determination of etoricoxib in human plasma. Chromatography was performed on an Acquity UPLC HSS T3 column (1.8 μm, 50 × 2.1 mm), with a flow rate of 0.600 mL/min, using a gradient elution with acetonitrile and water which contained 2 mm ammonium acetate as the mobile phase. Detection was carried out on Triple QuadTM 5500 mass spectrometer under positive‐ion multiple reaction monitoring mode. The respective mass transitions used for quantification of etoricoxib and etoricoxib‐d3 were m/z 359.0 → 280.1 and m/z 362.0 → 280.2. Calibration curves were linear over the concentration range of 5–5000 ng/mL. The validated method was applied in the pharmacokinetic study of etoricoxib in Chinese healthy volunteers under fed and fasted conditions. After a single oral dose of 120 mg, the main pharmacokinetic parameters of etoricoxib in fasted and fed groups were respectively as follows: peak concentration, 2364.78 ± 538.01 and 1874.55 ± 367.90 ng/mL; area under the concentration–time curve from 0 to 120 h, 44,605.53 ± 15,266.66 and 43,516.33 ± 12,425.91 ng h/mL; time to peak concentration, 2.00 and 2.50 h; and half‐life, 24.08 ± 10.06 and 23.64± 6.72 h. High‐fat food significantly reduced the peak concentration of etoricoxib (p = 0.001) but had no effect on the area under the concentration–time curve.     

Metabonomics study of the effects of traditional Chinese medicine formula Ermiaowan on hyperuricemic rats

To explore the global mechanism of Ermiaowan on hyperuricemia regulation, the holistic function of Ermiaowan for hyperuricemia in rats was firstly assessed by the urinary metabonomics method which was based on ultra‐high performance liquid chromatography with electrospray ionization quadrupole time‐of‐flight mass spectrometry. The urinary targeted metabonomics approach combined with the serum biochemical analysis and histological assay was conducted to verify the research result. As a result, the significant differences in metabolic profiles were observed from Ermiaowan‐treated group, model group, and healthy control group by using multivariate statistical approaches. Twenty therapeutic related metabolites were identified in response to the therapeutic effects of Ermiaowan, which were mainly associated with purine metabolism, pyrimidine metabolism, tryptophan metabolism, tricarboxylic acid cycle, and tyrosine metabolism. In addition, the urinary targeted metabonomics study showed that Ermiaowan can better restore the disturbed pathways than Phellodendri cortex and Atractylodis rhizome. The biochemical assay and histopathological assay confirmed that Ermiaowan could significantly reduce uric acid and fibrosis areas of kidney. These results provided new insights into the mechanism of Ermiaowan on hyperuricemia.     

Anti‐cancer potential of selenium‐ and tellurium‐containing species: opportunities abound!

An overview highlighting the anti‐cancer potential of (bio‐essential) selenium‐ and tellurium‐containing species, with an emphasis on biological targets and mechanisms of action, is presented. Studies thus far have focused on selenium(II) compounds (along with – to a lesser extent – inorganic selenium and selenium nanoparticles) which often successfully exploit the inherent anti‐oxidizing ability of selenium. Significantly less work has been conducted in developing anti‐cancer tellurium compounds, yet two tellurium(IV) species are proven, clinically, as anti‐cancer agents. Given the prevalence of the disease and the accumulated insights into mechanisms of action, the continued development of selenium‐ and tellurium‐containing molecules is an area deserving greater attention. Copyright © 2012 John Wiley & Sons, Ltd.     

Reaktion von Pyridin-2-Carbonsäure Mit Tetrabutylammonium-Tetrachloro-Nitridotechnetat(VI) Sowie Tetrabutylammonium-Tetrachlorooxotechnetat (V)

Abstract

The reaction of 2-pyridine carboxylic acid (Hpic) with (n-Bu₄N)[TcNCl₄] and (n-Bu₄N)[TcOCl₄] in ethanol and methanol, respectively, yields the dinuclear μ-oxo complex [(pic)₂NTc-O-TcN(pic)(Hpic)Cl] and the monomeric complex [TcO(pic)₂Cl].

Visible and infrared spectroscopy, ESR, ¹H-NMR and ⁹⁹Tc-NMR have been used to characterize the new compounds. The most important field of application for the new compounds synthesized is radiodiagnostics.     

Methodik und Anwendung des Radioimmunoassays

1. Einleitung

2. Tracerdarstellung

3. Geuinnung von Antiseren

4. Methoden zur Trennung von freier und antikörpergebundener Radioaktivität

5. Analysengang

6. Spezifität

7. Empfindlichkeit

8. Anwendungsbeispiele

9. Literatur     

Modified Preparation of 99mTe-Iron Hydroxide Macroaggregate (99mTe-Fe-(OH)2MA)

A modified method for preparing ^99mTc-FHMA for pulmonary studies is elabrated. It includes a new antioxidant sodium metabisulphite. The optimum conditions for the reparation are given. A simple and rapid procedure with a yield more than 98% is described which eliminates a further purification step.